Investing in the future of
healthcare technology

samrter-dx-team
Dr. Michael Gao & Dr. Joshua Geleris, SmarterDx

Healthcare is complex.

Success requires more than capital—it takes deep understanding, the right connections, and a long-term mindset. That is where we focus.

We partner with exceptional founders building companies that improve outcomes, lower costs, and reshape how healthcare works.

Rising Tides, 2023

~$1B

in assets under
management

83

portfolio
companies

22

portfolio company
exits

6

proprietary
co-creations

$500M

invested in
healthtech

Flare Capital Team, Annual Meeting 2026

Investing in the future of healthcare

Our team spans investors, operators, clinicians, and technologists who understand how the system actually works—and how hard it is to change. We help founders navigate that complexity, from early product decisions to scaling in regulated markets.

A network that moves companies forward

Our ecosystem includes leading payers, providers, and healthcare organizations, along with a highly engaged group of strategic investors and operators. These relationships help founders accelerate commercial traction, validate their approach, and open doors that would otherwise take years to unlock.

35
Industry Advisory Board Members
13
AI Advisory Council Members
509
Flare Scholars
Aaron Foster Aaron Foster
Alaa Halawa Alaa Halawa
Barry Stein, MD Barry Stein, MD
Beau Garverick Beau Garverick
Brenton Burns Brenton Burns
Cain A. Hayes Cain A. Hayes
Chase Tacker Chase Tacker
Christopher Eso Christopher Eso
Compass summit at fenway park
Rising Tides, 2023
Rising Tides, 2024

We work alongside founders to build enduring companies.

That includes helping recruit leadership teams, refine go-to-market strategy, and make critical decisions as the business scales. Our role is to be a consistent, high-conviction partner from the earliest stages through growth.

placeholder

We take a long-term, data-informed approach to investing.

We look for early signals of product-market fit, strong underlying economics, and the ability to scale within healthcare’s unique constraints. Our goal is to back companies that can grow into durable, category-defining businesses.

Seed to Series B
$5M–$30M
Total investment
10%–20%
Target ownership